This position will take a leadership role in developing global strategies and managing day-to-day intellectual property efforts to support multiple small molecule discovery, clinical development and commercial phase Neurocrine programs.
Your Contributions (include, but are not limited to):
Identification of inventions, patent drafting, and prosecution relating to small molecule pharmaceuticals;
Conducting strategic IP analysis and due diligence on the patent portfolios of Neurocrine’s competitors and potential collaborators for patentability and freedom-to-operate;
Identifying opportunities for expanding Neurocrine's IP position in collaboration with members of various discovery, development and business groups within Neurocrine;
Working and communicating with collaborators and other external strategic partners in connection with developing a global IP strategy;
Reviewing and negotiating license agreements and IP-related clauses in other agreements;
Manage ANDA litigation and other IP-related contentious matters; and
Managing the use of outside legal counsel globally.
At least 10 years of in-house and/or law firm patent experience related to small molecule drugs;
Registered to practice before the US Patent and Trademark Office;
A graduate degree in organic chemistry or an allied chemistry discipline required, Ph.D. preferred; and a Juris Doctorate and admission to practice law in a US state or the District of Columbia required;
Industrial or academic scientific experience in small molecule therapeutics discovery, development, and/or manufacturing preferred, but not required;
A broad range of patent-related legal expertise required, including patent preparation, both U.S. and foreign prosecution, IP due diligence, strategic counseling and management of contentious IP matters with a particular emphasis on small molecule therapies and other pharmaceutical subject matter;
Experience with managing small molecule pharmaceutical exclusivity related legal matters including brand-on-brand patent litigation strategies and the aspects of regulatory affairs related to market exclusivity would be a plus, but not required;
Exceptional communication skills, including presentation, interpersonal interactions, written work and conflict resolution with an ability to effectively interact with Neurocrine team members at every level in the organization and across a wide range of scientific knowledge levels;
Experience with Orange Book and Patent Term Extension practice for the US and SPC practice for Europe is preferred, but not required;
Ability to independently oversee legal matters, build and manage a small team of patent professionals (when and if needed), manage the use of outside legal counsel and work collaboratively with other personnel at Neurocrine; and
Ability to set aggressive deadlines, handle multiple complex legal matters and see projects through to conclusion.
Internal Number: R2580
About Neurocrine Biosciences
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.